Trial Profile

LEAPS influenza A virus vaccine-H1N1 in patients with influenza A virus H1N1 subtype

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 16 Nov 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza A virus vaccine-H1N1 (Primary)
Indications Influenza A virus H1N1 subtype
Focus Pharmacodynamics

Most Recent Events

06 Nov 2009 Status changed from planning to recruiting. CEL SCI announced in a media release that the Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for this clinical study to proceed.
22 Sep 2009 New trial record.
16 Sep 2009 US FDA approval for trial initiation.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com